X4 PHARMACEUTICALS, INC Investment Income, Interest
X4 PHARMACEUTICALS, INC (XFOR) reported Investment Income, Interest of $1.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- X4 PHARMACEUTICALS, INC investment income, interest for the quarter ending 2026-06-30 was $1.98M, a 197.59% increase year-over-year.
- X4 PHARMACEUTICALS, INC investment income, interest for the quarter ending 2026-03-31 was $2.10M, a 105.37% increase year-over-year.
- X4 PHARMACEUTICALS, INC investment income, interest for the quarter ending 2025-12-31 was $1.99M, a 56.67% increase year-over-year.
- X4 PHARMACEUTICALS, INC investment income, interest for the quarter ending 2025-09-30 was $901.00K, a 51.84% decline year-over-year.
- X4 PHARMACEUTICALS, INC investment income, interest for fiscal 2025 was $4.58M, a 20.68% decline from fiscal 2024.
- X4 PHARMACEUTICALS, INC investment income, interest for fiscal 2024 was $5.77M, a 25.91% increase from fiscal 2023.
- X4 PHARMACEUTICALS, INC investment income, interest for fiscal 2023 was $4.58M, a 1992.24% increase from fiscal 2022.
- X4 PHARMACEUTICALS, INC investment income, interest for fiscal 2022 was $219.00K, a 2090.00% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.98M 10-Q · filed 2026-08-06 | $4.08M 10-Q · filed 2026-08-06 | $6.07M derived: sum of 3 quarters · filed 2026-08-06 | $6.97M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.10M 10-Q · filed 2026-05-06 | $4.09M derived: sum of 2 quarters · filed 2026-05-06 | $4.99M derived: sum of 3 quarters · filed 2026-05-06 | $5.66M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $2.89M derived: sum of 2 quarters · filed 2026-03-17 | $3.55M derived: sum of 3 quarters · filed 2026-08-06 | $4.58M 10-K · filed 2026-03-17 | ||||
| 2025-09-30 | $901.00K 10-Q · filed 2025-11-05 | $1.57M derived: sum of 2 quarters · filed 2026-08-06 | $2.59M 10-Q · filed 2025-11-05 | $3.86M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $665.00K 10-Q · filed 2026-08-06 | $1.69M 10-Q · filed 2026-08-06 | $2.96M derived: sum of 3 quarters · filed 2026-08-06 | $4.83M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $1.02M 10-Q · filed 2026-05-06 | $2.29M derived: sum of 2 quarters · filed 2026-05-06 | $4.16M derived: sum of 3 quarters · filed 2026-05-06 | $5.73M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $3.14M derived: sum of 2 quarters · filed 2026-03-17 | $4.70M derived: sum of 3 quarters · filed 2026-03-17 | $5.77M 10-K · filed 2026-03-17 | ||||
| 2024-09-30 | $1.87M 10-Q · filed 2025-11-05 | $3.44M derived: sum of 2 quarters · filed 2025-11-05 | $4.50M 10-Q · filed 2025-11-05 | $5.95M derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2024-06-30 | $1.56M 10-Q · filed 2025-08-08 | $2.63M 10-Q · filed 2025-08-08 | $4.08M derived: sum of 3 quarters · filed 2026-03-17 | $5.46M derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2024-03-31 | $1.07M 10-Q · filed 2025-05-01 | $2.51M derived: sum of 2 quarters · filed 2026-03-17 | $3.90M derived: sum of 3 quarters · filed 2026-03-17 | $4.81M derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2023-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $2.83M derived: sum of 2 quarters · filed 2026-03-17 | $3.75M derived: sum of 3 quarters · filed 2026-03-17 | $4.58M 10-K · filed 2026-03-17 | ||||
| 2023-09-30 | $1.39M 10-Q · filed 2024-11-13 | $2.30M derived: sum of 2 quarters · filed 2024-11-13 | $3.14M 10-Q · filed 2024-11-13 | $3.33M derived: sum of 4 quarters · filed 2025-03-26 | ||||
| 2023-06-30 | $914.00K 10-Q · filed 2024-08-08 | $1.75M 10-Q · filed 2024-08-08 | $1.95M derived: sum of 3 quarters · filed 2025-03-26 | $1.96M derived: sum of 4 quarters · filed 2025-03-26 | ||||
| 2023-03-31 | $835.00K 10-Q · filed 2024-05-07 | $1.03M derived: sum of 2 quarters · filed 2025-03-26 | $1.05M derived: sum of 3 quarters · filed 2025-03-26 | $1.05M derived: sum of 4 quarters · filed 2025-03-26 | ||||
| 2022-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $212.00K derived: sum of 2 quarters · filed 2025-03-26 | $216.00K derived: sum of 3 quarters · filed 2025-03-26 | $219.00K 10-K · filed 2025-03-26 | ||||
| 2022-09-30 | $14.00K 10-Q · filed 2023-11-09 | $18.00K derived: sum of 2 quarters · filed 2023-11-09 | $21.00K 10-Q · filed 2023-11-09 | $24.00K derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2022-06-30 | $4.00K 10-Q · filed 2023-08-10 | $7.00K 10-Q · filed 2023-08-10 | $10.00K derived: sum of 3 quarters · filed 2024-03-21 | $12.00K derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2022-03-31 | $3.00K 10-Q · filed 2023-05-04 | $6.00K derived: sum of 2 quarters · filed 2024-03-21 | $8.00K derived: sum of 3 quarters · filed 2024-03-21 | $11.00K derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $5.00K derived: sum of 2 quarters · filed 2024-03-21 | $8.00K derived: sum of 3 quarters · filed 2024-03-21 | $10.00K 10-K · filed 2024-03-21 | ||||
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-03 | $5.00K derived: sum of 2 quarters · filed 2022-11-03 | $7.00K 10-Q · filed 2022-11-03 | $8.00K derived: sum of 4 quarters · filed 2023-03-21 | ||||
| 2021-06-30 | $3.00K 10-Q · filed 2022-08-04 | $5.00K 10-Q · filed 2022-08-04 | $6.00K derived: sum of 3 quarters · filed 2023-03-21 | $6.00K derived: sum of 4 quarters · filed 2023-03-21 | ||||
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-12 | $3.00K derived: sum of 2 quarters · filed 2023-03-21 | $3.00K derived: sum of 3 quarters · filed 2023-03-21 | $10.00K derived: sum of 4 quarters · filed 2023-03-21 | ||||
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | $1.00K derived: sum of 2 quarters · filed 2023-03-21 | $8.00K derived: sum of 3 quarters · filed 2023-03-21 | $273.00K 10-K · filed 2023-03-21 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $7.00K derived: sum of 2 quarters · filed 2021-11-04 | $272.00K 10-Q · filed 2021-11-04 | $573.00K derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2020-06-30 | $7.00K 10-Q · filed 2021-08-03 | $303.00K 10-Q · filed 2021-08-03 | $573.00K derived: sum of 3 quarters · filed 2022-03-17 | $1.04M derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2020-03-31 | $296.00K 10-Q · filed 2021-05-06 | $566.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.03M derived: sum of 3 quarters · filed 2022-03-17 | $1.42M derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2019-12-31 | $270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $734.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.13M derived: sum of 3 quarters · filed 2022-03-17 | $1.20M 10-K · filed 2022-03-17 | ||||
| 2019-09-30 | $464.00K 10-Q · filed 2020-11-05 | $858.00K derived: sum of 2 quarters · filed 2020-11-05 | $927.00K 10-Q · filed 2020-11-05 | $976.00K derived: sum of 4 quarters · filed 2021-03-19 | ||||
| 2019-06-30 | $394.00K 10-Q · filed 2020-08-04 | $463.00K 10-Q · filed 2020-08-04 | $512.00K derived: sum of 3 quarters · filed 2021-03-19 | $563.00K derived: sum of 4 quarters · filed 2021-03-19 | ||||
| 2019-03-31 | $69.00K 10-Q · filed 2020-05-07 | $118.00K derived: sum of 2 quarters · filed 2021-03-19 | $169.00K derived: sum of 3 quarters · filed 2021-03-19 | $236.00K derived: sum of 4 quarters · filed 2021-03-19 | ||||
| 2018-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $100.00K derived: sum of 2 quarters · filed 2021-03-19 | $167.00K derived: sum of 3 quarters · filed 2021-03-19 | $236.00K 10-K · filed 2021-03-19 | $809.00K 10-K · filed 2019-03-11 | |||
| 2018-09-30 | $51.00K 10-Q · filed 2019-11-07 | $196.00K 10-Q · filed 2018-11-09 | $118.00K derived: sum of 2 quarters · filed 2019-11-07 | $187.00K 10-Q · filed 2019-11-07 | $637.00K 10-Q · filed 2018-11-09 | $161.00K derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-06-30 | $67.00K 10-Q · filed 2019-08-07 | $225.00K 10-Q · filed 2018-08-13 | $136.00K 10-Q · filed 2019-08-07 | $441.00K 10-Q · filed 2018-08-13 | $110.00K derived: sum of 3 quarters · filed 2020-03-12 | $200.00K derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-03-31 | $69.00K 10-Q · filed 2019-05-15 | $216.00K 10-Q · filed 2018-05-10 | $43.00K derived: sum of 2 quarters · filed 2020-03-12 | $133.00K derived: sum of 3 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $64.00K derived: sum of 2 quarters · filed 2020-03-12 | $64.00K 10-K · filed 2020-03-12 | $214.00K 10-K · filed 2019-03-11 | ||||
| 2017-09-30 | $90.00K 10-Q · filed 2018-11-09 | $90.00K 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |